CZ-48

N/A

Report date: 2024/11/02 20:00:07
NME

Base Information

Drug NameCZ-48
Drug Alias NameCamptothecin-20-O-Propionate HydrateCZ-48
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsSolid tumoursLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNmt PharmaceuticalsCara Therapeutics IncChristus Stehlin Foundation For Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChristus Stehlin Foundation For Cancer ResearchCao Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursLymphoma

Other Information

ATC CodeN/A
Related LinksN/A